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Background. The hepatitis C virus is a major cause of hepatocellular carcinoma. Extrahepatic manifestations of hepatitis C
include mixed cryoglobulinemia which can result in ischemic damage to multiple organs. The management of these sequelae
in posthepatectomy patients is unclear. Case Report. A 49-year-old male with hepatitis C was found to have a 4cm hepatocellular
carcinoma on surveillance imaging. He underwent portal vein embolization followed by hepatectomy. His postoperative course
was complicated by the development of splenic infarcts, small bowel ischemia, skin lesions, and liver damage. Findings of
elevated cryocrit and elevated rheumatoid factor suggested the diagnosis of cryoglobulin-related vasculitis. The patient improved
on supportive care. Conclusion. Cryoglobulinemia is associated with hepatitis C and may complicate the care of this patient
population. The treatment of cryoglobulinemia posthepatectomy patients is complicated by concerns over how medications
may aﬀect the regenerating liver. Steroids should be used with caution in this setting. Summary. Brief report of hepatectomy
complicated by vasculitis in the context of hepatocellular carcinoma secondary to hepatitis C addresses the management of mixed
cryoglobulinemia in post-hepatectomy patients.
1.Background
Hepatitis C is the second most common viral infection
globally [1], and its role in hepatocellular carcinoma is
well established. Mixed cryoglobulinaemia is considered an
extrahepatic manifestation of chronic hepatitis C. While its
prevalence is high in patients with chronic hepatitis C [2],
post-hepatectomy vasculitis ﬂares are not well understood.
2.CaseReport
A 49-year-old Guinean male was diagnosed with hepatitis
C, genotype II in 2007. He was given a 6-month trial of
ribavirin and interferon without improvement in his viral
load. Recently, the patient was found to have a liver mass on
screening magnetic resonance imaging. The 4cm mass was
located in segment 6 and demonstrated hyperattenuation
on arterial phase and hypoattenuation on venous phase,
consistent with hepatocellular carcinoma (Figure 1). The
patient’s past medical history is signiﬁcant for hypertension
and history of intermittent lower extremity skin lesions.
previous biopsy of these skin lesions demonstrated leukocy-
toclastic vasculitis.
When evaluated by the surgical oncology service, the
patient reported a recent weight loss of 10lbs, occasional
fevers, and decreased appetite. Physical examination was
unremarkable, and there were no signs of ascites, malnutri-
tion, or hepatomegaly. Liver transaminases were mildly ele-
vated (aspartate aminotransferase 70U/L, alanine transam-
inase 89U/L) with a normal total bilirubin (0.7mg/dL).2 HPB Surgery
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Figure 1: Magnetic Resonance Imaging with arterial and venous phases demonstrating a mass in segment 6 consistent with hepatocellular
carcinoma.
Platelet count was 271×109/L, and albumin and coagulation
factors were within normal limits.
In preparation for surgical resection, the patient under-
went a right portal vein embolization with coils in order to
hypertrophy the liver remnant. The patient was discharged
the following day in a stable condition. Five weeks following
the right portal vein embolization the patient underwent a
computed tomography scan that demonstrated signiﬁcant
hypertrophy of the left lobe. Subsequently, the patient
underwent an uneventful right hepatectomy. The patient
tolerated the procedure well and did not require blood
transfusions. His postoperative course was uncomplicated,
and he was discharged home on postoperative day ﬁve at
which point his liver enzymes and bilirubin had returned
to their preoperative baseline. Pathologic evaluation of the
specimen conﬁrmed the presence of a 3.5cm hepatocellular
carcinomawithoutvascularinvasion.Inaddition,evaluation
of the gallbladder revealed incidental histologic evidence of
leukocytoclastic vasculitis.
On postoperative day 10, the patient presented to the
emergency department with abdominal pain, nausea, and
an episode of hematemesis. He denied fevers, chills, or
diarrhea. On examination, the patient was found to have
right 4th ﬁngertip erythema and edema. The patient’s liver
transaminases were elevated relative to discharge (aspartate
aminotransferase 450U/L, alanine transaminase 662U/L),
suggesting an acute hepatic insult. A computed tomography
scan demonstrated focal areas of small bowel thickening
and splenic infarcts, which were suggestive of embolic
disease. The patient underwent an emergent exploratory
laparoscopy to rule out small bowel ischemia. Findings
included diﬀuse patchy areas of hemorrhagic serositis along
the small intestine; however, there was no evidence of bowel
ischemia (Figure 2) and no bowel resection was performed.
Cultures of the peritoneal ﬂuid were negative for growth.
Given the patient’s presentation with four sites of
ischemic injury (small intestine, liver, spleen, skin), the diag-
nosis of embolic disease or systemic vasculitis was consid-
ered. Embolic work-up with transesophageal echocardio-
gram was negative, and computed tomography angiography
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Figure 2: Emergent exploratory laparoscopy ﬁndings of patchy
hemorrhagic serositis of the small intestine with adjacent areas of
normal bowel.
revealed a patent abdominal aorta and major branch vessels
without evidence of thrombus.
Given the patient’s history of hepatitis C infection as well
as that of skin lesions with evidence of leukocytoclastic vas-
culitis on biopsy, he was also evaluated for hepatitis C virus-
related vasculitides. The patient’s laboratory results were
signiﬁcant for an elevated rheumatoid factor (104IU/m), C3
and C4 were within normal limits (112mg/dL, 14.9mg/dL,
resp.), Anit-Nuclear antibodies and Anti-Neutrophil Cyto-
plasmic Antibodies were negative, urinalysis was within
normal limits, and the cryocrit was ≥3% on days 1 and
5. This led to a diagnosis of hepatitis C virus-related
cryoglobulinemia. The patient’s abdominal pain was self-
limited, and he recovered with supportive care and had
normal resumption of bowel function. His digital ischemia
persisted but remained stable. He was discharged home on
hospital day 10.
On outpatient follow-up, twelve days after discharge,
patient’s right 4th ﬁngertip had developed into a dry area
of eschar (Figure 3). Concerns regarding the progression
of the vascular insult to the patient’s ﬁnger lead to the
initiation of therapy consisting of prednisone 30mg once a
day as well as 10 days of amoxicillin/clavulanate and aspirin.HPB Surgery 3
Figure 3: Ischemic ulceration of right fourth digit ﬁnger tip.
Seven weeks after discharge, the patient is improving and the
digit is healing.
3. Discussion
Hepatitis C virus induced mixed cryoglobulinemia is one the
most severe and common extrahepatic manifestations of the
virus [3]. It is a systemic vasculitis resulting secondary to the
deposition of cryoglobulins, which are immune complexes
consisting of rheumatoid factor, IgG, hepatitis C virus
ribonucleicacid,andcomplement.Thestandingrelationship
between hepatitis C virus and mixed cryoglobulinemia
has established hepatitis C virus as a vital agent in the
pathogenesis of mixed cryoglobulinemia. Furthermore, the
severity of mixed cryoglobulinemia is correlated with the
severity of the hepatitis C [4].
Mixed cryoglobulinemia is characterized by a clinical
triad of skin lesions, arthralgia, and weakness accompa-
nied by a high serum rheumatoid factor [3]. It mainly
aﬀects small and medium sized vessels with the ﬁnding of
leukocyctolcastic vasculitis, which is the histological hall-
mark of mixed cryoglobulinemia [5]. The most commonly
involved organ is the skin with more than 90% of patients
presenting with intermittent skin lesions beginning in the
lower extremities [5]. In retrospect, the diagnosis of hepatitis
C virus-associated mixed cryoglobulinemia is consistent
with the patient’s past dermatologic history. Other clinical
manifestation of hepatitis C virus-induced mixed cryoglob-
ulinemia includes the progression of the purpuric lesions
to chronic ulcers and gangrene which could represent the
underlying etiology of the patient’s right 4th digit ﬁndings
[3].
Vasculitis involving multiple organs including the gas-
trointestinal tract is unusual. In a retrospective study of 49
patients with mixed cryoglobulinemia, the involvement of
the gastrointestinal tract presenting as abdominal pain was
described in 14% of the patients [6].
There is no diagnostic criterion for mixed cryoglobuline-
mia; however serologic testing for cryoglobulins is necessary
to determine the type of mixed cryoglobulinemia. While
cryoglobulins can be detected in 40%–60% of patients
with hepatitis C virus, cryoglobulinemia vasculitis develops
in only 5%–10% of those patients [7]. The presence of
the cryoglobulinemia plays a vital role in establishing the
diagnosis, however, the severity of the condition does not
correlate to the serum levels [5].
Even though there is no consensus on the optimum
treatment for mixed cryoglobulinemia, given the central
role that hepatitis C virus plays in the pathogenesis of
mixed cryoglobulinemia, the treatment of the underlying
viral infection is essential. Due to the potential side eﬀects,
treatment with ribavirin and alpha-interferon should only
be established after reviewing any contraindications [5]. The
treatment duration currently suggested is 12 months with
Peg-Interferonandribavirin[7].Immunosuppressiveagents,
normally a combination of corticosteroids, cyclophos-
phamide, and azathioprine, are reserved for patients with
severe disease [7]. Low dose corticosteroids are used to
manage minor manifestations of vasculitis but do not play
a role in severe cases with multiple organ involvement [7].
Case studies have shown plasmapheresis to be safe and that it
may play a role in the management of glomerulonephritis,
neuropathy, and purpura [3]. Rituximab is a promising
new treatment for MC as demonstrated by several studies.
The overall prognosis of mixed cryoglobulinemia is quite
unfavorable with the 10-year mean survival of only 50%–
60% [5].
The risk of steroid treatment in the immediate post-
hepatectomy period is unclear, and no human studies in the
literature address this issue. There are two areas of concern:
ﬁrst, steroid therapy may directly inhibit liver regeneration
and second, steroid-induced immunosuppression may lead
to a ﬂare of the underlying hepatitis. Whether steroids
retard liver regeneration in humans is unstudied, however
in animal models of hepatectomy, steroids have been shown
to aﬀect the regeneration of the liver remnant [8]. Rats
who were subjected to 70% hepatectomy and then started
on prednisone demonstrated fewer hepatic mitotic ﬁgures
than the control hepatectomy group [8]. In control rats, the
mitotic index was 1.77; in the rats given methylprednisolone
the mitotic index was 0.28 (P = .01) [8]. This phenomenon
may also impair regeneration of liver parenchyma in
human post-hepatectomy patients which is vital for clinical
recovery.
Inconclusion,hepatitisCvirus-relatedcryoglobulinemic
vasculitis is not uncommon and can manifest unexpectedly
with ischemic injury to multiple organ sites. In the case of
this patient, it is possible that the hepatectomy itself may
have caused the ﬂare of vasculitis. Post-operative hepatitis
ﬂares are known to occur, and since mixed cryoglobulinemia
is related to the course of the hepatitis C virus, it is
reasonable to suppose that the events are related. Given that
hepatitis C virus is the second most common chronic viral
infection,aswellasthepossible exacerbationofthevasculitis
secondary to surgery, surgeons involved with hepatitis C
patients need to be aware of this entity. Steroid therapy
in the regenerative phase following hepatectomy must be
used with caution since it may adversely aﬀect hepatic
regeneration.4 HPB Surgery
References
[1] G. M. Lauer and B. D. Walker, “Hepatitis C virus infection,”
New England Journal of Medicine, vol. 345, no. 1, pp. 41–52,
2001.
[2] F. Lunel, L. Musset, P. Cacoub et al., “Cryoglobulinemia in
chronic liver diseases: role of hepatitis C virus and liver
damage,”Gastroenterology,vol.106,no.5,pp.1291–1300,1994.
[3] E. D. Charles and L. B. Dustin, “Hepatitis C virus-induced
cryoglobulinemia,”KidneyInternational,vol.76,no.8,pp.818–
824, 2009.
[4] F. Dammacco, D. Sansonno, J. H. Han et al., “Nat-
ural interferon-α versus its combination with 6-methyl-
prednisolone in the therapy of type II mixed cryoglobulinemia:
a long-term, randomized, controlled study,” Blood, vol. 84, no.
10, pp. 3336–3343, 1994.
[5] C. Ferri, “Mixed cryoglobulinemia review,” Orphanet Journal of
Rare Diseases, vol. 3, no. 1, article 25, 2008.
[ 6 ]Y .H .L e e ,J .D .J i ,J .E .Y e o n ,K .S .B y u n ,C .H .L e e ,a n dG .
G. Song, “Cryoglobulinaemia and rheumatic manifestations
in patients with hepatitis C virus infection,” Annals of the
Rheumatic Diseases, vol. 57, no. 12, pp. 728–731, 1998.
[7] D. Saadoun, D. A. Landau, L. H. Calabrese, and P. P. Cacoub,
“Hepatitis C-associated mixed cryoglobulinaemia: a crossroad
between autoimmunity and lymphoproliferation,” Rheumatol-
ogy, vol. 46, no. 8, pp. 1234–1242, 2007.
[ 8 ] A .C .A .T a n n u r i ,U .T a n n u r i ,M .C .M .C o e l h o ,E .S .M e l l o ,a n d
N. A. S. R. Santos, “Eﬀects of immunosuppressants on hepato-
cyte cell mitosis during liver regeneration in growing animal
models of partial hepatectomy,” Transplantation Proceedings,
vol. 40, no. 5, pp. 1641–1644, 2008.